Public Employees Retirement System of Ohio Has $4.54 Million Stake in CareDx Inc (NASDAQ:CDNA)

Public Employees Retirement System of Ohio increased its stake in shares of CareDx Inc (NASDAQ:CDNA) by 15.9% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 126,100 shares of the company’s stock after acquiring an additional 17,300 shares during the period. Public Employees Retirement System of Ohio’s holdings in CareDx were worth $4,538,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. Aperio Group LLC acquired a new stake in CareDx during the second quarter worth approximately $31,000. First Quadrant L P CA acquired a new stake in shares of CareDx during the 2nd quarter valued at approximately $63,000. Resources Investment Advisors LLC. acquired a new stake in shares of CareDx during the 2nd quarter valued at approximately $212,000. Private Wealth Partners LLC acquired a new stake in shares of CareDx during the 2nd quarter valued at approximately $216,000. Finally, Steward Partners Investment Advisory LLC acquired a new stake in shares of CareDx during the 2nd quarter valued at approximately $222,000. 92.82% of the stock is currently owned by institutional investors and hedge funds.

In other news, CEO Peter Maag sold 50,000 shares of the stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $28.84, for a total value of $1,442,000.00. Following the completion of the transaction, the chief executive officer now owns 379,049 shares of the company’s stock, valued at $10,931,773.16. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider James P. Yee sold 20,000 shares of the stock in a transaction on Monday, June 17th. The stock was sold at an average price of $37.54, for a total value of $750,800.00. Following the completion of the transaction, the insider now directly owns 62,170 shares of the company’s stock, valued at approximately $2,333,861.80. The disclosure for this sale can be found here. Insiders sold 125,084 shares of company stock worth $4,288,055 over the last ninety days. 3.20% of the stock is owned by corporate insiders.

Several equities research analysts recently issued reports on the company. Raymond James upped their price target on CareDx from $46.00 to $48.00 and gave the company a “strong-buy” rating in a research report on Friday, August 2nd. TheStreet lowered CareDx from a “c” rating to a “d” rating in a research report on Thursday, May 23rd. Piper Jaffray Companies set a $63.00 price target on CareDx and gave the company a “buy” rating in a research report on Thursday, August 22nd. Zacks Investment Research raised CareDx from a “sell” rating to a “hold” rating in a research report on Wednesday, August 7th. Finally, HC Wainwright set a $43.00 target price on CareDx and gave the stock a “buy” rating in a research report on Friday, August 23rd. One research analyst has rated the stock with a sell rating, one has given a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. CareDx has an average rating of “Buy” and a consensus target price of $44.00.

NASDAQ CDNA traded up $0.69 during trading hours on Friday, hitting $22.65. The company had a trading volume of 23,069 shares, compared to its average volume of 695,244. CareDx Inc has a fifty-two week low of $19.11 and a fifty-two week high of $41.27. The business has a fifty day simple moving average of $26.01 and a 200-day simple moving average of $31.27. The firm has a market cap of $848.95 million, a P/E ratio of -17.47 and a beta of 1.04.

CareDx (NASDAQ:CDNA) last issued its earnings results on Thursday, August 1st. The company reported ($0.19) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.12) by ($0.07). CareDx had a negative return on equity of 47.53% and a negative net margin of 38.29%. The company had revenue of $31.45 million during the quarter, compared to analyst estimates of $27.96 million. On average, equities research analysts expect that CareDx Inc will post -0.7 earnings per share for the current fiscal year.

CareDx Profile

CareDx, Inc operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Further Reading: What is an overbought condition?

Want to see what other hedge funds are holding CDNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CareDx Inc (NASDAQ:CDNA).

Institutional Ownership by Quarter for CareDx (NASDAQ:CDNA)

Receive News & Ratings for CareDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareDx and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit